Solbec have almost completed the last leg of their phase I trials, continuous infusion. The preliminary results of this trial should be known in the next month or so. One patient from the previous trials (2 and 4hr infusion) experience tumor reduction of 80% so there's a chance that the continuous infusion could eliminate the tumor entirely. Watch this space...
SBP
solbec pharmaceuticals limited
